A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031

Clinical trial NCT00814736 · COMPLETED

Trial details

NCT number: NCT00814736
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Hyperplasia Urinary Bladder, Overactive Erectile Dysfunction

Start date: 2008-08-01
Primary completion: 2008-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.